Discussion
MINOR
Our overarching research objective was to examine complex implementation mechanisms that may explain variations in behavior-related outcomes, such as the adoption of innovation. To this end, we examined the relations between the three meso- and micro-level factors, organizational readiness for change, contextualized innovation effectiveness beliefs, and adoption. The findings indicate that an organizationally triggered mechanism lead to the adoption of innovation. The study further demonstrates how contextualized innovation beliefs function within the mechanism, which contributes to a broader understanding of the mechanism.The empirical findings of this study contribute to the literature on realist evaluation research, organizational change, and the study of implementation mechanisms [Regarding the last hypothesis, the control factors had no direct or indirect effects and only the regional variable exhibited minor effects. The results indicate that the implementation of digital innovation in urban or rural physician practices is significant. We can derive one possible explanation for this from our qualitative data collection; compared to physicians from rural areas, physicians from urban areas report that they are less knowledgeable about the medical histories and medications of some of their patients, because they see some patients only briefly. Therefore, it is more likely that they will expect additional benefit from using a digital innovation that provides patient-relevant information.In this paper, we presented a novel approach to SEM mediation analysis that integrates qualitative findings from a context-mechanism-outcome configuration (realist inquiry) and a data-driven latent construct. In addition, the synergistic effects of the two analytic approaches of realist evaluation and SEM were explored. To the best of our knowledge and compared to previous studies in the field of polypharmacy management research [The current state of research on polypharmacy indicates that there is an urgent worldwide need to simplify the complex clinical practice of polypharmacy management, because an increasing number of elderly and multimorbid patients will be affected by polypharmacy, and the workload of primary care physicians who care for these patients with complex medication regimens will increase [